Pharmaceutical Technology on MSN
Rocket ditches blood disorder gene therapy in ongoing pipeline pivot
Rocket has pulled an approval application to the FDA, with the biotech considering offloading the asset via external ...
AZoLifeSciences on MSN
New Partnership Brings Next-Generation Cell Isolation Solutions to Researchers Advancing Cell and Gene Therapy Development
Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell ...
"RUBY"—a cost-effective innovation designed to track gene activity—is proving valuable across a range of fields. It all ...
Life sciences ranked among the top four sectors, with a notable rise of companies integrating AI and biotech in ...
One of the NCBiotech portfolio companies there is Elysia Bio, founded in 2021 by Raleigh native and CEO Eli Hornstein, Ph.D.
The investment from Brown parents Giammaria and Sabrina Giuliani will support scholars seeking to unlock the potential of RNA ...
Many applications—from drug discovery and diagnostics to cell engineering and gene modulation—require delivering biomolecules ...
That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene ...
Earth’s most diverse biological entities are the viruses that infect bacteria, called bacteriophages (phages). They are rich ...
Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results